Updated November 18, 2009
Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine (11/18/09)
This issue brief, created by the Center for Biosecurity of UPMC, describes the licensing process for the 2009 H1N1 vaccine and the surveillance systems used to monitor adverse events.
Quick Facts for Clinicians on Antiviral Treatments for 2009 H1N1 (11/9/09)
This CDC document lists some of the key facts to consider when deciding if a patient needs to be treated with antiviral medications.
Studies Suggest N-95 and Surgical Masks Offer Equal H1N1 Protection
Australian researchers have retracted their recommendation that heath care workers treating H1N1 patients should use N95 respirators.
Public Guidance Regarding Emergency Department Use for H1N1 Flu Symptoms (10/15/09)
Guidance from the American College of Emergency Physicians on seeking emergency care for flu-like symptoms.
Microsoft Develops H1N1 Flu Self-Assessment Site, Based on Emory University Materials (10/7/09)
ACEP Resources:
Siguen Incrementándose los Casos de H1N1 a Nivel Nacional - Los Médicos de Emergencia Llevan a CAabo una Campaña para Dar a Conocer al Público Cuándo Deben Buscar Ayuda de Emergencia - Comunicado de Prensa
Una Nueva Encuesta Revela qua Cerca del 90 Por Ciento de los Médicos de Emergencia Están Preocupados por la Capacidad de las Salas de Emergencia para Atender a Pacientes Adicionales de la Gripe
CDC Q and A on 2009 H1N1 Influenza Vaccine
Get answers to your questions concerning the H1N1 (Swine Flu) vaccine.
Webinar: Overview of The National Strategic Plan for Emergency Department Management of Outbreaks of Novel H1N1 Influenza
H1N1 National Strategic Plan
This plan was developed to define critical capabilities and suggest high-level actions to achieve them.
Influenza Pandemic Emergency Preparedness – Waiver of Certain Medicare Requirements
Provisions for temporarily waiving EMTALA duty under a disaster scenario (as opposed to H1N1) were included in the Pandemic and All Hazards Preparedness Act of 2006 (P.L. 109-417).
FAQ’s for Emergency Departments in Epidemic or Pandemic Influenza Outbreaks
Developed by ACEP’s H1N1 (Swine Flu) Guidance Review Team
(PDF version)
Submit your questions and best practice documents to ACEP's Guidance Review Team
Best Practices for Hospital Preparedness
Developed by the Disaster Preparedness and Response Committee, this document was approved by the ACEP Board in April 2009.
Respiratory Hygiene in the Emergency Department
Published in Annals of Emergency Medicine November 2006, this article was written by ACEP’s Public Health Committee.
Congressional Testimony on Fighting Pandemic Flu
ACEP Board member David C. Seaberg testified in February 2006 before the House Committee on Homeland Security on "Protecting the Homeland: Fighting Pandemic Flu from the Front Lines." A corresponding press release summarizes his testimony.
Lessons Learned from the SARS Epidemic
This article was published in the ACEP Section of Disaster Medicine newsletter, July 2003
ASPR Influenza Surge Preparedness Assesment
This project was originally supported by the U.S. Department of Homeland Security, Office of Grants and Training.
Related ACEP Policy Statements
Disaster Planning and Response -- Approved June 2008
Emergency Department Utilization During Outbreaks of Influenza -- Approved November 2004
Immunization of Adults and Children in the Emergency Department – Approved January 2008
CDC
CDC Q and A on 2009 H1N1 Influenza Vaccine
Preliminary Research and Reports from H1N1 Vaccine Trials
H1N1Flu (Swine Flu)
Links to CDC Guidance:
Treatment Guidance
Antiviral Recommendations
Facemask and Respirator Use
Reducing Risks in the Community (Community Mitigation)
Emergency Use Authorization (EUA) of Medical Products
Clinician Guidance for Specific Audiences
Patients With Cardiovascular Disease
HIV-Infected Adults and Adolescents
Pregnant Women
Young Children
Day and Residential Camps in Response to Human Infections with the Novel Influenza A (H1N1) Virus
Screening & Specimen Collection
Use of Rapid Influenza Diagnostic Tests
Guidelines for the Submission of Tissue Specimens for the Pathologic Evaluation of Influenza Virus Infections
Case Definitions for Investigations of Cases
Screening in Regions with Few or no Reported Cases
Specimen Collection, Processing, and Testing for Suspected Infection
Biosafety Guidelines for Lab Workers
Other Helpful Links:
